Phytomedics
Dayton
About Phytomedics
Phytomedics is committed to quality, technological innovation and research. Their powerful portfolio of overlapping proprietary technologies is targeted to turning green plants into reliable vehicles for discovering and manufacturing proprietary botanical pharmaceuticals and nutraceuticals. NewLeadTM and RhizexTM elicitation and optimization processes greatly enhance the efficacy and reproducibility of plant-derived products and increase the synergy between various chemical components of plant extracts. The Company has developed an efficient and proprietary discovery and lead prioritization process based on high-power bio-informatics, high-tech data mining, efficient activity screening, and an extensive network of international collaborations.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2007)
- Website: phytomedics.com
Industries & Categories
Biotechnology, Manufacturing, Nutraceutical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/phytomedics-3311986 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.